Clinical and Experimental Rheumatology is a bi-monthly international peer-reviewed journal which has been covering all clinical, experimental and translational aspects of musculoskeletal, arthritic and connective tissue diseases since 1983.

Annual Supplements

In addition to regular issues, it also publishes a number of annual supplements dedicated to the following topics:

• Contemporary Topics in Clinical Rheumatology, since 1999;
• Behçet’s disease and other autoinflammatory conditions, since 2001;
• Vasculitis, since 2003;
• Scleroderma, since 2009;
• Fibromyalgia and related syndromes, since 2009;
• Sjögren’s syndrome, since 2018

Starting in 2022 a new annual issue on Myositis will be published. This monothematic issue will also be the official organ of the International Myositis Society (iMyoS, https://imyos.org).

Articles submitted on these topics are processed with the same peer-review criteria as those published in the regular issues. Once accepted, they are published ahead-of-print online, and subsequently included in the correspondent supplement issue, unless otherwise expressly requested by the Authors.

Articles published in the supplements share the same citation coverage and impact factor as the main journal (PubMed, Scopus, Science Citation Index, etc.).

Editor-in-Chief
Stefano Bombardieri, MD

LER & CER: Letter to the Editor Rheumatology

Letter to Editor Rheumatology: Commentaries and Controversies (LER) has been an online forum for a stronger voice and a wider audience for critical and dissenting views in rheumatology and related disciplines. It has joined forces with Clinical and Experimental Rheumatology to achieve the deserved wider audience.

Letters can be submitted solely to: https://www.clinexprheumatol.org, please read Authors’ Guidelines.

Page charge

A page charge of €100.00 will be assessed for all articles published. Instructions for payment will be sent to authors along with the proofs. There is no charge for solicited articles.